Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC    

Global Antiinfectives for Systemic Use Market Research Report

PRODUCT TITLE PUBLISHED
Cocciliosis Cocciliosis
Cocciliosis and Infectious Bronchitis, Gumboro Disease,
Upcoming
Marek disease Marek disease
Marek disease and Infectious Bronchitis, Gumboro Disease,
Upcoming
New castle disease New castle disease
New castle disease and Infectious Bronchitis, Gumboro...
Upcoming
Porcine parvovirus Porcine parvovirus
Porcine parvovirus and Porcine Circovirus II, Swine...
Upcoming
Porcine Circovirus II Porcine Circovirus II
Porcine Circovirus II and Porcine parvovirus, Swine Influenza,...
Upcoming
Swine Influenza Swine Influenza
Swine Influenza and Porcine parvovirus, Porcine Circovirus...
Upcoming
Swine pneumonia Swine pneumonia
Swine pneumonia and Porcine parvovirus, Porcine Circovirus...
Upcoming
Porcine Reproductive Respiratory Syndrome (PRRS) Porcine Reproductive Respiratory Syndrome (PRRS)
Porcine Reproductive Respiratory Syndrome (PRRS) and Porcine parvovirus,
Upcoming
Equine Encephalomyelitis Equine Encephalomyelitis
Equine Encephalomyelitis and Strangles, Equine Influenza,
Upcoming
Strangles Strangles
Strangles and Equine Encephalomyelitis, Equine...
Upcoming
Equine Influenza Equine Influenza
Equine Influenza and Equine Encephalomyelitis, Strangles,
Upcoming
Equine Rhinopneumonitis Equine Rhinopneumonitis
Equine Rhinopneumonitis and Equine Encephalomyelitis,
Upcoming
Vibriosis Vibriosis
Vibriosis and Pasteurellosis, Furunculosis and
Upcoming
Pasteurellosis Pasteurellosis
Pasteurellosis and Vibriosis, Furunculosis and
Upcoming
Furunculosis Furunculosis
Furunculosis and Vibriosis, Pasteurellosis and
Upcoming
North America Live attenuated vaccines North America Live attenuated vaccines
The North American Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $805 million in 2013 and expected to be $999 million by 2018 at a CAGR of 4.4%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
European Live attenuated vaccines Market European Live attenuated vaccines Market
The European Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $956 million in 2013 and expected to be $1253 million by 2018 at a CAGR of 5.6%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Asian Live attenuated vaccines Market Asian Live attenuated vaccines Market
The Asian Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $428 million in 2013 and expected to be $745 million by 2018 at a CAGR of 11.7%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
North American Inactivated vaccines Market North American Inactivated vaccines Market
The North American Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $627 million in 2013 and expected to be $818 million by 2018 at a CAGR of 5.5%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
European Inactivated vaccines Market European Inactivated vaccines Market
The European Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $744 million in 2013 and expected to be $1026 million by 2018 at a CAGR of 6.6%. European Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
75 reports | Show
Connect With Us
US/CAN : +1-888-502-0539